The 1999 PDR "RM" guarantees you the security and safety of having up-to-minute official FDA-approved information on over 4,000 prescription drugs and important data on more than 250 drug manufacturers.
New drugs features in this edition include Amerge and Zomig, two new oral 5-HT1 receptor agonists used to treat migraine headaches; Evista, a new treatment option for osteoporosis: Aggrastat and Integrilin, used for acute coronary syndrome; Meridia, a new obesity treatment option: Trovan, a new broad spectrum anti-bacterial agent; Rebetron. a combination therapy for chronic hepatitis C; Viagra, a new oral treatment option tot erectile dysfunction; Plavix, a new oral antiplatelet agent used to reduce the incidence of atherosclerotic events and Prandin, a new oral treatment for type 2 diabetes. Of course, updated information of vital importance for many established drugs has also been included.
